Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa

Current Medical Research and Opinion

Volumn 24, Issue 12, 2008, Pages 3531-3542

  Drehobl, Margaret ^a   Guerrero, Juan Lorente ^b   Lacarte, Pilar Rivas ^c   Goldstein, Gary ^d   Mata, Francisco Sabater ^e   Luber, Stephen ^f  

^a SCRIPPS CLINIC   (United States)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL DE VILADECANS   (Spain)

^d Tampa Bay Medical Research Inc   (United States)

^e HOSPITAL CLÍNIC   (Spain)

^f Rockwood Clinic   (United States)

Author keywords

Ciprofloxacin otic solution 0.2 ; Efficacy; Otitis externa; Polymyxin B neomycin hydrocortisone otic solution

Indexed keywords

CIPROFLOXACIN; HYDROCORTISONE; NEOMYCIN; POLYMYXIN B; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; APPLICATION SITE PAIN; BACTERIUM CULTURE; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EAR DISCOMFORT; EAR DISEASE; EAR PRURITUS; EXTERNAL OTITIS; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OTALGIA; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE BLIND PROCEDURE; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; TREATMENT RESPONSE; ACUTE DISEASE; ARTICLE; COMPARATIVE STUDY; DRUG COMBINATION; MIDDLE AGED; SOLUTION AND SOLUBILITY; SPAIN; TOPICAL DRUG ADMINISTRATION; UNITED STATES;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; DRUG COMBINATIONS; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NEOMYCIN; OTITIS EXTERNA; PHARMACEUTICAL SOLUTIONS; POLYMYXIN B; SPAIN; UNITED STATES;

EID: 62349092138     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990802583845     Document Type: Conference Paper

References (42)

1. Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope 2002;112:1166-1177
2. Arshad M, Khan NU, Ali N, et al. Sensitivity and spectrum of bacterial isolates in infectious otitis externa. J Coll Physicians Surg Pak 2004;14:146-149
3. Dibb WL. Microbial aetiology of otitis externa. J Infect 1991;22:233-239
4. Battikhi MN, Ammar SI. Otitis externa infection in Jordan. Clinical and microbiologic features. Saudi Med J 2004;25:1199-1203
5. Sander R. Otitis externa: a practical guide to treatment and prevention. Am Fam Physician 2001;63:927-936
6. Osguthorpe JD, Nielsen DR. Otitis externa: review and clinical update. Am Fam Physician 2006;74:1510-1516
7. Rosenfeld RM, Brown L, Cannon CR, et al. Clinical practice guidelines: acute otitis externa. Otolaryngol Head Neck Surg 2006;134:S4-23
8. van Asperen IA, de Rover CM, Schijven JF, et al. Risk of otitis externa after swimming in recreational fresh water lakes containing Pseudomonas aeruginosa. BMJ 1995;311:1407-1410
9. Hannley MT, Denneny JC III, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg 2000;122:934-940
10. Dohar JE. Evolution of management approaches for otitis externa. Pediatr Infect Dis J 2003;22:229-308
11. Roland PS, Pien FD, Schultz CC, et al. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxinB/hydrocortisone for otitis externa. Curr Med Res Opin 2004;20:1175-1183
12. Torun B, Block SL, Avila H, et al. Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial. Clin Ther 2004;26:1046-1054
13. Pistorius B, Westberry K, Drehobl M, et al. Prospective, randomized, comparative trial of ciprofloxacin otic drops, with or without hydrocortisone, vs. polymyxin B-neomycin-hydrocortisone otic suspension in the treatment of acute diffuse otitis externa. Infect Dis Clin Pract 1999;8:387-395
14. Block SL. Otitis externa: providing relief while avoiding complications. J Fam Pract 2005;54:669-676
15. Beers SL, Abramo TJ. Otitis externa review. Pediatr Emerg Care 2004;20:250-256
16. Cantrell HF, Lombardy EE, Duncanson FP, et al. Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials. South Med J 2004;97:465-471
17. Jones RN, Milazzo J, Seidlin M. Ofloxacin otic solution for treatment of otitis externa in children and adults. Arch Otolaryngol Head Neck Surg 1997;123:1193-1200
18. Schwartz RH. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa. Curr Med Res Opin 2006;22:1725-1733
19. Arnes E, Dibb WL. Otitis externa: clinical comparison of local ciprofloxacin versus local oxytetracycline, polymyxin B, hydrocortisone combination treatment. Curr Med Res Opin 1993;13:182-186
20. Goldenberg D, Golz A, Netzer A, et al. The use of otic powder in the treatment of acute external otitis. Am J Otolaryngol 2002;23:142-147
21. Vallés H. Evaluation of the efficacy and safety of topic otic ciprofloxacin (0.3%) in the treatment of diffuse external otitis and chronic middle otitis [in Spanish]. ORL-DIPS 2000;27:9-14
22. Quesada P, Lorente J, Arjona F, et al. Multicenter drug surveillance study on topic otic ciprofloxacin 0.3% in children affected with diffuse otitis externa [in Spanish]. Rev Esp Pediatr 1998;54:195-202
23. Quesada P, Lorente J, García M, et al. Multicenter drug surveillance study on topical ciprofloxacin in patients affected with diffuse otitis externa [in Spanish]. Salud Rural 1999;7:119-129
24. Clarós Blanch P, Sánchez García F, Rodríguez Leal A, et al. Clinical study to evaluate the effectiveness of 0.3% ciprofloxacin in children with diffuse external otitis [in Spanish]. Acta Pediatr Esp 2000;58:358-362
25. Ganz H. Local antibiotic therapy of bacterial ear infections [in German]. HNO 1989;37:386-388
26. Stange G. Local treatment of Pseudomonas infection of the ear [in German]. Laryngorhinootologie 1989;68:653-656
27. Miniti A, Ubirajara Sennes L, Bento RF. Topic treatment of acute external otitis and acute and chronic media otitiswith ciprofloxacin 0.5% [in Portuguese]. Rev Bras Med 1993;50:675-676
28. Garcia Rodriguez JA, Garcia Sanchez JE, Garcia Garcia MI, et al. Efficacy of topical ciprofloxacin in the treatment of ear infections in adults. J Antimicrob Chemother 1993;31:452-453
29. De Schepper S, Schmelzer B. Local treatment of otitis media and otitis externa: the role of quinolones [in Dutch]. Acta Otorhinolaryngol Belg 1994;48:67-70
30. Conroy PJ. New quinolone/steroid combination for topical treatment of acute otitis: early- and late-phase study results. Ear Nose Throat J 2003;82(Suppl.):1-4
31. Rosenfeld RM, Singer M, Wasserman JM, et al. Systematic review of topical antimicrobial therapy for acute otitis externa. Otolaryngol Head Neck Surg 2006;134(4 Suppl.):S24-S48
32. Bojrab DI, Bruderly T, Abdulrazzak Y. Otitis externa. Otolaryngol Clin North Am 1996;29:761-782
33. Myer CM. The evolution of ototopical therapy: From cumin to quinolones. Ear Nose Throat J 2004;83(Suppl.):9-11
34. Rutka J. Acute otitis externa: treatment perspectives. Ear Nose Throat J 2004;83(9 Suppl. 4):20-22
35. Simpson KL, Markham A. Ofloxacin otic solution: a review of its use in the management of ear infections. Drugs 1999;58:509-531
36. McCoy SI, Zell ER, Besser RE. Antimicrobial prescribing for otitis externa in children. Pediatr Infect Dis J 2004;23:181-183
37. Blackwelder WC. "Proving the null hypothesis" in clinical trials. Control Clin Trials 1982;3:345-353
38. Clark WB, Brook I, Bianki D, et al. Microbiology of otitis externa. Otolaryngol Head Neck Surg 1997;116:23-25
39. Wilkinson SM, Beck MH. Hypersensitivity to topical corticosteroids in otitis externa. J Laryngol Otol 1993;107:597-599
40. Wright CG, Roland PS. Middle ear effects of ototopical agents. In: Roland P, Rutka J., eds. Ototoxicity. Hamilton, ON: BC Decker Inc., 2004
41. Spandow O, Anniko M, Hellstrom S. Hydrocortisone applied into the round window niche causes electrophysiological dysfunction of the inner ear. ORL J Otorhinolaryngol Relat Spec 1989;51:94-102
42. Perrenoud D, Bircher A, Hunziker T, et al. Frequency of sensitization to 13 common preservatives in Switzerland. Contact Dermatitis 1994;30:276-279